Volume 22, Number 9—September 2016
Research
Ebola Virus Disease, Democratic Republic of the Congo, 2014
Carolina Nanclares, Jimmy Kapetshi, Fanshen Lionetto, Olimpia de la Rosa, Jean-Jacques Muyembe Tamfun, Miriam Alia, Gary Kobinger, and Andrea Bernasconi
Table 2
Symptoms and signs, and their prediction for death, among patients admitted to 2 Ebola treatment centers during the Ebola virus disease outbreak, Lokolia and Boende, Democrtic Republic of the Congo, July–November 2014
| Hemorrhagic signs | ||||||
|---|---|---|---|---|---|---|
| >1 of the signs below | 2 (15. 4) | 5 (41.7) | 7 (28.0) | 71.4 | 1.83 (0.87–3.87) | 0.2 |
| Bloody feces | 1 (7.7) | 4 (33.3) | 5 (20.0) | 80.0 | 2 (1–3.9) | 0.16 |
| Hematemesis | 0 | 3 (25.0) | 3 (12.0) | 100.0 | 2.44 (1.48–4.04) | 0.09 |
| Red eyes/subconjunctival hemorrhage | 1 (7.7) | 1 (8.3) | 2 (8.0) | 50.0 | 1 (0.24–4.45) | 1 |
| Epistaxis | 0 | 1 (8.3) | 1 (4.0) | 100.0 | 2.18 (1.41–3.37) | 0.48 |
| Gingival/oral bleeding | 0 | 1 (8.3) | 1 (4.0) | 100.0 | 2.18 (1.41–3.37) | 0.48 |
| Nonmenstrual vaginal bleeding | 0 | 1 (8.3) | 1 (4.0) | 100.0 | 2.18 (1.41–3.37) | 0.48 |
Page created: August 16, 2016
Page updated: August 16, 2016
Page reviewed: August 16, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.